EFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDY

Baraliakos, XenofonWitte, TorstenDe Clerck, LucFrediani, BrunoCollantes-Estevez, EduardoKatsifis, GkikasVanlunen, BrendaKleine, ElisabethHoepken, BengtGoodson, Nicola2025-01-072025-01-072019-06-010003-4967https://hdl.handle.net/10668/25428enEFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDYconference outputopen access10.1136/annrheumdis-2019-eular.17071468-2060https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1811.1.full.pdf472207105396